{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:44:47Z","timestamp":1761155087260,"version":"3.33.0"},"reference-count":45,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1185\/030079907x233278","type":"journal-article","created":{"date-parts":[[2007,9,15]],"date-time":"2007-09-15T19:45:54Z","timestamp":1189885554000},"page":"2617-2625","source":"Crossref","is-referenced-by-count":3,"title":["Long dosing intervals in the treatment of postmenopausal osteoporosis"],"prefix":"10.1185","volume":"23","author":[{"given":"E.","family":"Michael Lewiecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2007,9,13]]},"reference":[{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1734-y"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1640-3"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/0169-6009(91)90139-Q"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.94.5.823"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1490-4"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1702-6"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00198-004-1680-8","volume":"16","author":"Vestergaard P","year":"2005","journal-title":"Mosekilde L. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.4065\/77.4.334"},{"key":"CIT0012","first-page":"767","volume":"15","author":"Elliot-Gibson V","year":"2004","journal-title":"DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int"},{"key":"CIT0013","first-page":"856","volume":"80","author":"Recker R","year":"2005","journal-title":"Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.4065\/81.8.1013"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1750"},{"key":"CIT0016","first-page":"1701","volume":"291","author":"Anderson GL","year":"2004","journal-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA"},{"key":"CIT0017","first-page":"321","volume":"288","author":"Rossouw JE","year":"2002","journal-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2018s Health Initiative randomized controlled trial. JAMA"},{"key":"CIT0018","first-page":"1729","volume":"290","author":"Cauley JA","year":"2003","journal-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2018s Health Initiative randomized trial. JAMA"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01536.x"},{"key":"CIT0020","first-page":"637","volume":"282","author":"Ettinger B","year":"1999","journal-title":"Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(03)00241-2"},{"key":"CIT0023","first-page":"125","volume":"355","author":"Barrett-Connor E","year":"2006","journal-title":"al., for the Raloxifene Use for The Heart (RUTH) Trial Investigators. Effects of raloxi fene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000200249.12006.6e"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1612-7"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.05.007"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936050-00002"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040325"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07088-2"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077"},{"key":"CIT0042","first-page":"1988","volume":"17","author":"Rizzoli R","year":"2002","journal-title":"Two-year results of once-weekly administration of alendronate 70 mg for the treat ment of postmenopausal osteoporosis. J Bone Miner Res"},{"key":"CIT0043","first-page":"1344","volume":"282","author":"Harris ST","year":"1999","journal-title":"Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1185\/030079903125003125"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440503"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125003566"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044958"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.10.969"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011807"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.7.1007"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044459"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040305"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.20.2414"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X61875"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X74862"},{"key":"CIT0061","first-page":"1968","volume":"32","author":"Ettinger MP","year":"2005","journal-title":"J Rheumatol"},{"key":"CIT0062","first-page":"1638","volume":"17","author":"Carr AJ","year":"2006","journal-title":"Cooper C. Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int"},{"key":"CIT0063","first-page":"1117","volume":"89","author":"Clowes JA","year":"2004","journal-title":"Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079907X233278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:44:59Z","timestamp":1737420299000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079907X233278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,13]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2007,9,12]]},"published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1185\/030079907X233278"],"URL":"https:\/\/doi.org\/10.1185\/030079907x233278","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"type":"print","value":"0300-7995"},{"type":"electronic","value":"1473-4877"}],"subject":[],"published":{"date-parts":[[2007,9,13]]}}}